| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ticarcillin disodium (substance) |
Is a |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ticarcillin measurement (procedure) |
Component |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ticarcillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ticarcillin adverse reaction |
Causative agent (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to ticarcillin (finding) |
Causative agent (attribute) |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing clavulanic acid and ticarcillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clavulanate potassium gm/ticarcillin disodium gm injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ticarcillin+clavulanic acid 3g/0.1g infusion 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ticarcillin + clavulanate potassium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ticarcillin and clavulanic acid adverse reaction |
Causative agent (attribute) |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to ticarcillin and clavulanic acid |
Causative agent (attribute) |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to ticarcillin (finding) |
Causative agent (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to ticarcillin and clavulanic acid |
Causative agent (attribute) |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ticarcillin disodium (substance) |
Is modification of (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Clavulanic acid- and ticarcillin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Clavulanic acid and ticarcillin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ticarcillin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Clavulanic acid and ticarcillin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to ticarcillin and clavulanic acid |
Causative agent (attribute) |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only ticarcillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing ticarcillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ticarcillin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]